KATHRYN FULLER: Open Payments
NPI 1881331593 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 47 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $450 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $337 |
| Novo Nordisk Inc | 4 | $171 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 3 | $36 |
| Forte Bio-Pharma LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $15 |
Products named: QULIPTA, Ozempic, UBRELVY, XIFAXAN, VOQUEZNA, AIRSUPRA, VRAYLAR, Wegovy.
Industry payments across NC — which companies pay providers there.
